Health Policy
Estimating Number of COVID Vaccine Deaths in America - Updated October 8, 2021
Updated October 8, 2021
By Steve Kirsch, Jessica Rose, Mathew Crawford
Abstract:
Analysis of the Vaccine Adverse Event Reporting System (VAERS) database can be used to estimate the number of excess deaths caused by the COVID vaccines. A simple analysis shows that it is likely that over 150,000 Americans have been killed by the current COVID vaccines as of August 8, 2021.
Winning the War Against Therapeutic Nihilism & Trusted Treatments vs Untested Novel Therapies
Interview with Dr. Ryan Cole About Ivermectin and Covid-19
Safety and efficacy of a MEURI Program for the use of high dose ivermectin in COVID-19 patients
Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States
Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021
September, 2021
Abstract
A nosocomial outbreak of SARS-CoV-2 Delta variant infected 42 patients, staff and family members; 39 were fully vaccinated. The attack rate was 10.6% (16/151) among exposed staff and reached 23.7% (23/97) among exposed patients in a highly vaccinated population, 16–26 weeks after vaccination (median: 25 weeks). All cases were linked and traced to one patient. Several transmissions occurred between individuals wearing face masks. Fourteen of 23 patients became severely sick or died, raising a question about possible waning immunity.
Effectiveness of mRNA COVID-19 Vaccines Against the Delta Variant
September 28, 2021
Slides - Effectiveness of mRNA COVID-19 Vaccines Against the Delta Variant
Covid-19 Lockdown Cost/Benefits: A Critical Assessment of the Literature
No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups Infected with SARS-CoV-2 Delta Variant
September, 2021
Abstract
We found no significant difference in cycle threshold values between vaccinated and unvaccinated, asymptomatic and symptomatic groups infected with SARS-CoV-2 Delta. Given the substantial proportion of asymptomatic vaccine breakthrough cases with high viral levels, interventions, including masking and testing, should be considered for all in settings with elevated COVID-19 transmission.